EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:754281 - lirilumab
| ChEBI ID | CHEBI:754281 |
| ChEBI Name | lirilumab |
| Stars | |
| Last Modified | 29 June 2026 |
| Submitter | ChEMBL |
| Roles Classification |
|---|
| Application: | antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| lirilumab (CHEBI:754281) has role antineoplastic agent (CHEBI:35610) |
| lirilumab (CHEBI:754281) is a organic molecular entity (CHEBI:50860) |
| INN | Source |
|---|---|
| lirilumab | WHO MedNet |
| Synonyms | Source |
|---|---|
| Anti-KIR Antibody | ChEMBL |
| BMS-986015 | ChEMBL |
| BMS-986015-01 | ChEMBL |
| BMS-98601501 | ChEMBL |
| IPH-2102 | ChEMBL |
| IPH2102 | ChEMBL |